“This is a big idea coming from a small lab,” said Associate Professor of Surgery Justin Pollara. He was presenting an update on a research project developed with Paul Cray, Senior Lab Research Analyst. A couple years back, they had come up with a novel, non-viral gene therapy platform and sought out internal Duke resources […]

OTC licensing managers are creative partners to Duke inventors – just ask pathologist Dr. Soman Abraham and OTC’s Dr. Dennis Thomas.

Growing up in New York state, Anna Kudla loved the outdoors. “We had the four seasons,” says Kudla. “I got a taste of the cycle of life, experiencing really stunning summers – lots of wildflowers everywhere, lots of insects.” That love of the outdoors would soon carry Kudla to college, abroad to rainforests, and to […]

FLAGSTAFF, Ariz. (August 12, 2022) – W. L. Gore & Associates, Inc. (Gore), a global material science company dedicated to transforming industries and improving lives, announced the acquisition of InnAVasc Medical, Inc., a privately held medical technology company focused on advancing care for patients with end stage renal disease who utilize graft circuits for dialysis treatment. “The […]

Polarean Imaging plc (AIM: POLX), the medical imaging technology company, announces that the U.S. Food and Drug Administration (“FDA”) has granted approval for its drug device combination product, XENOVIEW. XENOVIEW, prepared from the Xenon Xe 129 Gas Blend, is a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (“MRI”) for evaluation of lung ventilation in […]

“When I was a child, my cousin had a heart defect,” remembers Dr. Muath Bishawi, a Cardiothoracic Surgery Resident at the Duke University School of Medicine Department of Surgery. “I was curious: How could you have a hole in your heart?” Sporting green scrubs, Bishawi has just emerged from an hours-long heart transplant surgery – yet he’s still […]

SAN DIEGO, CA and DURHAM, NC (June 22, 2023) – Solve Therapeutics, Inc. (SolveTx), a biopharmaceutical company developing novel antibody-based therapeutics, announces the acquisition of Cereius, Inc. (Cereius), a private company developing innovative next-generation, targeted radiodiagnostics and radiotherapeutics for cancer patients. Cereius was co-founded by Professor Michael Zalutsky and Dr. Kimberly Lynn Blackwell around technology initially developed at Duke University and further advanced […]

If you’ve met Duke University Professor Bruce Donald, you know he is passionate about computer science and its applications. Heck, you may have even read one of his five books on topics including robotics, artificial intelligence, and most recently, computational biology. What you may not know is how wide-ranging Donald’s interests are, how he got into the field, […]

Larry Carin, former Duke vice president of research in IonQ’s early days and now provost at King Abdullah University of Science and Technology in Saudi Arabia, was an advocate of the company and actively recruited Kim to the university when he first came to Durham. Jungsang Kim wouldn’t say he’s changing the culture of innovation […]

“On the surface, as a Ph.D. student, you are an independent contributor – but you work collaboratively with other students on projects in the lab,” Cambre Kelly said. “That kind of work taught me a lot about solving hard problems.” But she isn’t going at it alone. Together with a mentor and a strong team built during […]

DURHAM, N.C.–A collaborative therapeutic development endeavor between researchers at Duke University and The University of Manchester has received funding from Four Points Innovation, LLC. Four Points Innovation, LLC, a private company wholly-owned by affiliates of Deerfield Management, a healthcare investment firm, was established as a vehicle to facilitate the research collaboration between Duke and Deerfield Management and is focused on supporting […]

On January 27, 2023, the Food and Drug Administration (FDA) approved elacestrant (Orserdu, Stemline Therapeutics, Inc.) for postmenopausal women or adult men with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. FDA also approved the Guardant360 CDx assay as a companion diagnostic device to […]

DURHAM, N.C.–(BUSINESS WIRE)–Tellus Therapeutics, a neonatal care company developing treatments for newborns in the neonatal intensive care unit (NICU), announced today the closing of a Series A financing round of $35 million led by the Perceptive Xontogeny Venture Fund (“PXV Fund”). The capital will be used to continue important preclinical work conducted through the seed […]

An innovative biomanufacturing start-up spun out of Duke University, Isolere Bio, has recently been acquired by a global maker of filtration products, Donaldson Company. As she was finishing her Ph.D. program at the Duke University Pratt School of Engineering, Kelli Luginbuhl was ready to dive into industry: not by joining an established company, but by starting her own. Alongside her advisor, the […]

“Could it be small enough to be flown?” an investor asked out of the audience. “With the proper funding!” responded the entrepreneur on stage, to chuckles and knowing smiles around the auditorium. Though the Research Triangle area of North Carolina is a hotbed of technology innovation, turning these great ideas into successful and sustainable companies […]